Science
Mechanism of Action
Horse Amnion Extract operates by supplying a biological scaffold rich in extracellular matrix components, growth factors, chemokines, and cytokines. This intricate composition contributes to its proposed regenerative, anti-inflammatory, anti-microbial, anti-apoptotic, and anti-fibrotic properties. These mechanisms collectively support improved epithelialization, fostering better tissue quality and potentially accelerating healing, with its protein content considered a primary contributor to its efficacy.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Demonstrated a 3.4-fold increase in wound contraction rate at 20 days and a 2-fold improvement by 60 days, alongside a 3.1-fold increase in closure per day in equine full-thickness distal limb wounds compared to controls. Safety was established within this context.
- 02 Topical application did not significantly enhance the re-epithelialization rate for experimentally induced equine superficial corneal ulcers when compared to conventional medical therapy alone.
- 03 Local injection resulted in 72% of horses with tendonitis or desmitis lesions returning to or exceeding their original level of work.
Transparency
Dusting Analysis
No data available to indicate common dusting practices or specific thresholds for this ingredient in cosmetic formulations.
The Formula
Formulation
Stability
The integrity of amniotic membrane, from which the extract is derived, is best preserved through frozen storage, typically at -80°C or between -10°C to -24°C. For fresh material, prompt collection and processing within 1 hour of foaling or refrigeration for up to 12 hours is recommended. Processing methods can impact stability and appearance; dilute chlorhexidine may cause tissue edema and layer separation, while iodine/acetic acid can result in yellow staining.
Conflicts
- Dilute chlorhexidine (potential for edematous tissue and layer separation)
- Iodine/acetic acid (potential for yellow staining)
Safety
Safety Profile
No dedicated CIR or SCCS safety assessment for cosmetic applications has been published. The FDA considers human amniotic fluid products, particularly for treating diseases, as drugs requiring premarket approval; currently, none are FDA-approved. Regulatory actions have been taken against some equine amniotic tissue products intended for animal use due to their status as unapproved new animal drugs. Safety for human cosmetic use remains broadly unassessed by relevant bodies.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Horse Amnion Extract exhibits compelling regenerative and healing properties in documented veterinary studies, a distinct lack of comprehensive clinical trials and safety assessments specific to human cosmetic applications renders its current utility for precision skincare highly questionable without further research.
Related
Similar Ingredients
Finding similar ingredients…